WallStreetZenWallStreetZen

NASDAQ: ALGN
Align Technology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ALGN

Based on 8 analysts offering 12 month price targets for Align Technology Inc

Min Forecast
$154.00+17.06%
Avg Forecast
$196.63+49.46%
Max Forecast
$245.00+86.23%

Should I buy or sell ALGN stock?

Based on 8 analysts offering ratings for Align Technology Inc.

Buy
Strong Buy
3 analysts 37.5%
Buy
2 analysts 25%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ALGN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ALGN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ALGN stock forecasts and price targets.

ALGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-31
lockedlocked$00.00+00.00%2025-07-31
lockedlocked$00.00+00.00%2025-07-31
lockedlocked$00.00+00.00%2025-07-31
lockedlocked$00.00+00.00%2025-07-09
Evercore ISI Group
Bottom 7%
7
BuyMaintains$200.00+52.02%2025-05-01
Mizuho
Bottom 6%
6
BuyMaintains$245.00+86.23%2025-04-29
HSBC
Top 48%
53
HoldDowngrades$170.00+29.22%2025-04-25
UBS
Top 17%
84
HoldMaintains$215.00+63.42%2025-04-24

1 of 1

Forecast return on equity

Is ALGN forecast to generate an efficient return?

Company
20.99%
Industry
26.25%
Market
-52.16%
ALGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALGN forecast to generate an efficient return on assets?

Company
13.21%
Industry
13.6%
ALGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALGN earnings per share forecast

What is ALGN's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$8.12+36.64%
Avg 2 year Forecast
$8.78+47.76%
Avg 3 year Forecast
$9.81+65.15%
ALGN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ALGN revenue forecast

What is ALGN's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$4.0B+1.11%
Avg 2 year Forecast
$4.2B+4.98%
Avg 3 year Forecast
$4.4B+10.18%
ALGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALGN earnings growth forecast

How is ALGN forecast to perform vs Medical Devices companies and vs the US market?

Company
17.38%
Industry
11.46%
Market
15.29%
ALGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ALGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ALGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ALGN revenue growth forecast

How is ALGN forecast to perform vs Medical Devices companies and vs the US market?

Company
3.2%
Industry
7.51%
Market
10.83%
ALGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALGN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ALGN$131.56$196.63+49.46%Buy
PEN$272.73$308.78+13.22%Strong Buy
MASI$147.44$195.75+32.77%Strong Buy
GMED$58.74$74.83+27.40%Strong Buy
BIO$280.34$333.50+18.96%Strong Buy
View Top Medical Device Stocks

Align Technology Stock Forecast FAQ

Is Align Technology Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ALGN) stock is to Buy ALGN stock.

Out of 8 analysts, 3 (37.5%) are recommending ALGN as a Strong Buy, 2 (25%) are recommending ALGN as a Buy, 3 (37.5%) are recommending ALGN as a Hold, 0 (0%) are recommending ALGN as a Sell, and 0 (0%) are recommending ALGN as a Strong Sell.

If you're new to stock investing, here's how to buy Align Technology stock.

What is ALGN's earnings growth forecast for 2025-2027?

(NASDAQ: ALGN) Align Technology's forecast annual earnings growth rate of 17.38% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 11.46%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.29%.

Align Technology's earnings in 2025 is $437,608,000.On average, 6 Wall Street analysts forecast ALGN's earnings for 2025 to be $588,350,103, with the lowest ALGN earnings forecast at $569,017,989, and the highest ALGN earnings forecast at $605,261,173. On average, 6 Wall Street analysts forecast ALGN's earnings for 2026 to be $636,191,106, with the lowest ALGN earnings forecast at $614,684,401, and the highest ALGN earnings forecast at $657,451,358.

In 2027, ALGN is forecast to generate $711,091,270 in earnings, with the lowest earnings forecast at $711,091,270 and the highest earnings forecast at $711,091,270.

What is ALGN's revenue growth forecast for 2025-2027?

(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 3.2% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Align Technology's revenue in 2025 is $3,964,802,000.On average, 6 Wall Street analysts forecast ALGN's revenue for 2025 to be $290,578,350,479, with the lowest ALGN revenue forecast at $288,560,982,371, and the highest ALGN revenue forecast at $292,656,462,163. On average, 6 Wall Street analysts forecast ALGN's revenue for 2026 to be $301,694,062,525, with the lowest ALGN revenue forecast at $295,418,192,784, and the highest ALGN revenue forecast at $307,674,187,885.

In 2027, ALGN is forecast to generate $316,655,103,908 in revenue, with the lowest revenue forecast at $304,330,391,730 and the highest revenue forecast at $334,208,547,756.

What is ALGN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ALGN) forecast ROA is 13.21%, which is lower than the forecast US Medical Devices industry average of 13.6%.

What is ALGN's Price Target?

According to 8 Wall Street analysts that have issued a 1 year ALGN price target, the average ALGN price target is $196.63, with the highest ALGN stock price forecast at $245.00 and the lowest ALGN stock price forecast at $154.00.

On average, Wall Street analysts predict that Align Technology's share price could reach $196.63 by Jul 31, 2026. The average Align Technology stock price prediction forecasts a potential upside of 49.46% from the current ALGN share price of $131.56.

What is ALGN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ALGN) Align Technology's current Earnings Per Share (EPS) is $5.94. On average, analysts forecast that ALGN's EPS will be $8.12 for 2025, with the lowest EPS forecast at $7.85, and the highest EPS forecast at $8.35. On average, analysts forecast that ALGN's EPS will be $8.78 for 2026, with the lowest EPS forecast at $8.48, and the highest EPS forecast at $9.07. In 2027, ALGN's EPS is forecast to hit $9.81 (min: $9.81, max: $9.81).

What is ALGN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ALGN) forecast ROE is 20.99%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.